Last reviewed · How we verify
NCT04890275
Blood Flow Restricted Resistance Training in Peripheral Arterial Disease
NA trial testing Blood flow restricted resistance exercise (BFR) in Peripheral Arterial Disease in 30 participants. Completed in 30 April 2022.
5 March 2022
Quick facts
| Lead sponsor | Sheffield Hallam University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 21 April 2021 |
| Primary completion | 5 March 2022 |
| Estimated completion | 30 April 2022 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Blood flow restricted resistance exercise (BFR)
- Resistance exercise without blood flow restricted (NON-BFR)
Conditions studied
- Peripheral Arterial Disease — all drugs for Peripheral Arterial Disease →
Sponsor
Sheffield Hallam University
Who can join
18 and older, any sex, with Peripheral Arterial Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A randomised controlled trial evaluating the feasibility and acceptability of a 12 week lower body blood flow restricted resistance exercise programme for people with peripheral arterial disease.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Low-intensity resistance exercise with blood flow restriction for patients with claudication: A randomized controlled feasibility trial.
Parkington T, Broom D, Maden-Wilkinson T, Nawaz S, et al · · 2023 · cited 4× · PMID 37819259 · DOI 10.1177/1358863x231200250
Verify or expand the search:
- PubMed search for NCT04890275
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Peripheral Arterial Disease
Currently open trials in the same condition.
- NCT05437562 — Randomized Clinical Trial for Ewing Amputation in the VA · NA · recruiting
- NCT07427108 — Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety · NA · recruiting
- NCT07336381 — Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy · NA · recruiting
- NCT07076082 — Vascular Trial Associated Registry Pilot · Phase 4 · recruiting
- NCT06308562 — Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease · NA · recruiting
Other Sheffield Hallam University trials
Trials by the same sponsor.
- NCT07373483 — Observing 3-5 Year Old Children's Use of Interactive Electronic Devices (IED) in the Family Home to Understand the Conte · recruiting
- NCT07585474 — Gut Microbiome Response to Long-Haul Travel in Elite Football Players · NA · enrolling by invitation
- NCT06810570 — The Effect of Mobile Devices on the Development and Health of Young Children · recruiting
- NCT06094517 — What Are Persistent Lower Back Pain Patients' Views of Sleep Health Within an Outpatient Musculoskeletal Physiotherapy S · unknown
- NCT06101875 — Health Coaching for Patients Waiting for Hip or Knee Replacements · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04890275 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sheffield Hallam University
- Last refreshed: 8 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04890275.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing